Add to ORKGThe metabolic syndrome, as a cluster of cardiovascular risk factors, may represent an important connection between cancer treatment and its common late effect of cardiovascular disease. Insight into the aetiology of the metabolic syndrome after cancer treatment might help to identify and treat cancer survivors with increased cardiovascular risk. In this review, we summarise current knowledge on the prevalence and pathophysiology of the metabolic syndrome in cancer survivors, and discuss current intervention strategies with an emphasis on new developments.</p
Aims. - The metabolic syndrome (MetS) is a risk factor for cancer. However, it is not known if the M...
Aims: The metabolic syndrome (MetS) is a risk factor for cancer. However, it is not known if the Met...
AIMS: The metabolic syndrome (MetS) is a risk factor for cancer. However, it is not known if the Met...
The metabolic syndrome, as a cluster of cardiovascular risk factors, may represent an important conn...
With increasing numbers of cancer survivors, attention has been drawn to long-term complications of ...
Cardiovascular diseases represent one of the most common and serious late complications of anticance...
Cardiovascular diseases represent one of the most common and serious late complications of anticance...
Metabolic syndrome is a cluster of risk factors that lead to cardiovascular morbidity and mortality....
Increasing numbers of long-term cancer survivors face important treatment related adverse effects. C...
Background & aims: This study was conducted to examine the prevalence of and lifestyle factors a...
The improvement in childhood cancer treatments resulted in a marked improvement in the survival of p...
BACKGROUND: The metabolic syndrome (MS) might increase the risk of cardiovascular disease in testicu...
Metabolic syndrome has become a major public health problem worldwide and represents a common clinic...
The aim of this study was to assess the risk of metabolic syndrome (MetS) in postmenopausal breast c...
Aims. - The metabolic syndrome (MetS) is a risk factor for cancer. However, it is not known if the M...
Aims: The metabolic syndrome (MetS) is a risk factor for cancer. However, it is not known if the Met...
AIMS: The metabolic syndrome (MetS) is a risk factor for cancer. However, it is not known if the Met...
The metabolic syndrome, as a cluster of cardiovascular risk factors, may represent an important conn...
With increasing numbers of cancer survivors, attention has been drawn to long-term complications of ...
Cardiovascular diseases represent one of the most common and serious late complications of anticance...
Cardiovascular diseases represent one of the most common and serious late complications of anticance...
Metabolic syndrome is a cluster of risk factors that lead to cardiovascular morbidity and mortality....
Increasing numbers of long-term cancer survivors face important treatment related adverse effects. C...
Background & aims: This study was conducted to examine the prevalence of and lifestyle factors a...
The improvement in childhood cancer treatments resulted in a marked improvement in the survival of p...
BACKGROUND: The metabolic syndrome (MS) might increase the risk of cardiovascular disease in testicu...
Metabolic syndrome has become a major public health problem worldwide and represents a common clinic...
The aim of this study was to assess the risk of metabolic syndrome (MetS) in postmenopausal breast c...
Aims. - The metabolic syndrome (MetS) is a risk factor for cancer. However, it is not known if the M...
Aims: The metabolic syndrome (MetS) is a risk factor for cancer. However, it is not known if the Met...
AIMS: The metabolic syndrome (MetS) is a risk factor for cancer. However, it is not known if the Met...